Friday, 23 October 2026European Markets

Goldman Sachs exits consumer banking after $4B in losses, refocuses on institutional finance

Goldman Sachs has sold its Marcus loan portfolio, GreenSky platform, and Personal Financial Management unit while offloading the Apple Card program to JPMorgan by 2026. The Wall Street bank absorbed roughly $4 billion in consumer banking losses before pivoting to institutional finance through its new Capital Solutions Group and acquisitions of Industry Ventures and Innovator Capital Management in 2025.

Goldman Sachs exits consumer banking after $4B in losses, refocuses on institutional finance
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Goldman Sachs has completed its retreat from consumer banking after accumulating approximately $4 billion in losses, selling Marcus loans in 2023, the GreenSky platform in 2024, and transferring the Apple Card program to JPMorgan in 2026. Creative Planning acquired Goldman's Personal Financial Management unit in 2023.

The exit contrasts sharply with Goldman's 2016 consumer banking launch. Mortgage loan origination costs at Fannie Mae and Freddie Mac average $13,000 per loan, illustrating the cost burden traditional banks face in retail operations. Specialized fintech firms and digital-native lenders operate with lower overhead structures.

Goldman formed its Capital Solutions Group in 2025 and acquired Industry Ventures and Innovator Capital Management the same year. The bank is consolidating around institutional clients, investment banking, and asset management—businesses where relationship complexity and deal size favor traditional investment banks over automated platforms.

European universal banks face similar pressure. Deutsche Bank, BNP Paribas, and UBS maintain both retail and institutional operations, but AI-driven cost advantages increasingly favor specialized players. Digital banks like N26 and Revolut handle routine retail transactions at lower cost per customer than traditional branches.

Goldman's strategic shift raises questions about European banking structure. Universal banking models rely on cross-subsidization between retail deposits and investment banking operations. If retail banking becomes structurally unprofitable for institutions lacking scale or digital efficiency, European banks may need to choose specialization.

EU banking competition could intensify as U.S. investment banks concentrate on institutional clients in Europe while fintech companies capture retail segments. Goldman's European operations focus on corporate advisory, capital markets, and wealth management for high-net-worth clients—areas less vulnerable to AI disruption than mass-market lending.

The pattern suggests a bifurcation: specialized fintech for standardized retail services versus relationship-driven banks for complex institutional finance. European regulators face challenges maintaining competitive retail banking markets if economies of scale and AI automation create winner-take-all dynamics favoring either massive digital platforms or niche institutional players.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,475 source documents archived
Query this data → isubstrate.com